Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Total Liabilities (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Total Liabilities for 7 consecutive years, with $7.6 million as the latest value for Q1 2025.

  • Quarterly Total Liabilities rose 118.32% to $7.6 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Mar 2025, up 118.32% year-over-year, with the annual reading at $5.0 million for FY2024, 16.42% up from the prior year.
  • Total Liabilities hit $7.6 million in Q1 2025 for Benitec Biopharma, up from $3.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $7.6 million in Q1 2025 to a low of $1.4 million in Q2 2021.
  • Historically, Total Liabilities has averaged $3.7 million across 5 years, with a median of $3.5 million in 2024.
  • Biggest five-year swings in Total Liabilities: skyrocketed 258.29% in 2021 and later tumbled 46.85% in 2024.
  • Year by year, Total Liabilities stood at $3.2 million in 2021, then fell by 8.4% to $2.9 million in 2022, then soared by 102.1% to $5.9 million in 2023, then crashed by 46.85% to $3.1 million in 2024, then skyrocketed by 144.29% to $7.6 million in 2025.
  • Business Quant data shows Total Liabilities for BNTC at $7.6 million in Q1 2025, $3.1 million in Q4 2024, and $4.6 million in Q3 2024.